Mobithron Xtra for knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This study tests a supplement called Mobithron Xtra to see if it helps reduce knee pain and improve function in people with moderate knee osteoarthritis. You will take the supplement for 3 months, and your progress will be checked regularly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- Your knee osteoarthritis must be confirmed by X-ray and be moderate (Grade 2 or 3 on the Kellgren-Lawrence scale), but not severe (Grade 4).
- You should have knee pain that is at least moderate, rated 5 or higher on a 0-10 pain scale.
- You cannot take pain relievers (like paracetamol or NSAIDs) or supplements like glucosamine or Mobithron while in the trial.
- You cannot have had a knee injection in the past 6 months, and you must not have had or be planning knee surgery within 3 months.
- You should not have other types of arthritis (like rheumatoid or post-traumatic arthritis) or serious health conditions that might interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a supplement called Mobithron Advance to see if it can slow down knee osteoarthritis over time. It may help people with mild to moderate knee arthritis find a non-surgical option.
This study tests whether wearing a knee brace and doing muscle training exercises can help people with knee osteoarthritis feel better and move more easily. It may be a good option if you have not had knee surgery and are not already in another treatment program.
This trial tests whether a herbal supplement helps people with osteoarthritis of the knee or hip feel less pain and move better. If you have moderate to severe pain and are able to walk, this study might be a good fit.
This study is testing whether a natural supplement made from Antarctic krill oil can help reduce knee pain from osteoarthritis. It's a Phase 2 trial, meaning researchers are still checking if it works and is safe.
This trial tests an injection called PTP-001 (MOTYS) for people with mild to moderate knee osteoarthritis. It aims to see if the injection can reduce knee pain and improve function.
This study compares two types of gentle knee movement treatments to see which one better reduces pain and improves function in people with knee osteoarthritis. If you have moderate knee osteoarthritis, this trial may help you find a more effective way to manage your symptoms.
Hear when a new Osteoarthritis (OA) of the Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.